期刊文献+

急性冠状动脉综合征患者血清超敏C-反应蛋白水平变化及其影响因素 被引量:2

Changes and relevant influence factors of high sensitivity C-reactive protein of patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨急性冠状动脉综合征(ACS)患者血清超敏C-反应蛋白(hsCRP)和心肌肌钙蛋白I(cTnI)变化及其影响因素。方法①采用化学发光免疫分析法检测50例ACS患者、20例OMI患者和20名健康人的hsCRP和cTnI含量。②以hsCRP为因变量,以年龄、性别、高血压史、糖尿病史、吸烟史、cTnI、甘油三酯(TG)、胆固醇(CHO)、载脂蛋白A(APOA)、载脂蛋白B(APOB)、血糖(GLU)、高密度脂蛋白胆固醇(HDL-C)、尿酸(URI)为自变量进行多元逐步回归分析。结果①ACS组的hsCRP、cTnI均高于OMI组和对照组(P<0.05);OMI组的hsCRP、cTnI水平与对照组相比有升高趋势,但差别无统计学意义(P>0.05)。②以hsCRP作为因变量的多元逐步回归方程式为:hsCRP=-3.362+0.02446X7+1.097X9(X7为cTnI,X9为CHO,X7、X9显著性均为P<0.01)。结论ACS患者血清hsCRP、cTnI水平明显升高;血清hsCRP水平和cTnI、CHO呈正相关。 Objective To investigate the relationship between serum high sensitivity C-reactive protein (hsCRP), Cardiac Troponin I(cTnI ) and the incidence of major cardiac events of the patients with acute coronary syndrome(ACS), the levels of serum hsCRP and cTnI were detected 8-12 h after acute chest pain in the patients with ACS. Methods (1)hsCRP,cTnI were measured by way of a chemiluminescence immunoassay. (2)The affecting factors of age,gender,history of hypertension, diabetes mellitus,history of smoking,cTnI,TG,CHO,APOA,APOB,GLU,HDL-C and URI were analynized in a Multiple Stepwise Regression model with the hsCRP as the dependent variable. Results (1)Serum hsCRP and cTnI were higher in the ACS group than that in the OMI and Control group (P〈0.05). The hsCRP and cTnI in the OMI group were higher than that in the control group,but no statistical significance (P〉0.05). (2)The Multiple Stepwise Regression equation was: hsCRP=-3.362 +0.02446X7 + 1.097X9 ( X7 : cTnI, X9 : CHO, P〈0.01 ).It suggested that hsCRP is positively associated with cTnI and CHO. Conclusion Serum hsCRP,cTnI are significantly higher in the ACS group than those in the OMI and control group (P〈0.05). Serum hsCRP of the ACS group is positively related with cTnI and CHO.
出处 《中国心血管病研究》 CAS 2006年第10期747-749,共3页 Chinese Journal of Cardiovascular Research
关键词 急性冠状动脉综合征 C反应蛋白质 肌钙蛋白I Acute coronary syndrome C-reactive protein Troponin I
  • 相关文献

参考文献12

  • 1[1]Fuster V,Badimon L,Badimon JJ,et al.The pathogenesis of coronary artery disease and the acute coronary syndromes.N Engl J Med,1992,326:242-250.
  • 2[2]Conti CR.Updated pathhophysiologic concepts in unstable coronary artery disease.Am Heart J,2001,141:12-14.
  • 3[3]Maseri A.Inflammation,atherosclerosis,and ischemic events:exploring the hidden side of the moon.N Engl J Med,1997,336:1014-1016.
  • 4[4]Ross R.Atheroscleroisi:an inflammatory disease.N Engl J Med,1999,340:115-126.
  • 5[5]Torzewski J,Torzewski M,Bowyer DE,et al.C-reactive protein frequently colocalizes with the terminal complement complex intima of early atherosclerotic lesions of human coronary arteries.Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
  • 6刘东,刘增长,董军,邓昌明,黄晶,李增高.冠心病患者C反应蛋白的临床意义及阿司匹林的影响[J].临床心血管病杂志,2000,16(2):64-65. 被引量:28
  • 7[7]Ferreios ER,Boissonnet CP,Pizarro R,et al.Independent prognostic value of elevated C-reactive protein in unstable angina.Circulation,1999,100:1958-1963.
  • 8[8]Ridker PM,Glynn R J,Henneken CH.C-reactive protein adds to the predictive value of tptal and HDL cholsterol in determinimg risk of first myocardial infarction.Circulation,1998,97:2007 -2011.
  • 9[9]Mendall MA,Patel P,Ballam L,et al.C-reactive protein and its relation to cardiovascular risk factors:a population based cross sectional study.BMJ,1996,312:1061-1065.
  • 10[10]Haverkate F,Thompson SG,Pyke SD,et al.Production of C-reactive protein and risk of coronary events in stable and unstab1e angina.European concerted action on thrombosis and disabilities angina pectoris study group.Lancet,1997,349:462-466.

二级参考文献23

  • 11 Alexander R W.Inflammation and coronary artery disease.N Engl J Med,1994,331:468~469
  • 22 Berk B C,Weintraub W S,Alexander R W.Elevation of C-reactive protein in “active” coronary disease.Am J Cardiol,1990,65:168~172
  • 33 DeBeer F C,Hird C R,Fox K M,et al.Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction.Br Heart J,1982,47:239~243
  • 44 Frits H,Simon G P,Stephen D M,et al.Production of C-reactine protein and risk of coronary events in stable and unstable angina.Lancet,1997,349:462~466
  • 5[1]Strachan DP, Carrington D, Mendall MA, et al. Relation of chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. BMJ, 1999, 318 (7190): 1 035-039
  • 6[2]Manuel M, Stefan K, Johann W, et al. Infections, immunity and atherosclerosis. Circulation, 2000, 102: 833-839
  • 7[3]Merja R, Marit VK, Timo P, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation, 2000, 101: 252-257
  • 8[4]Dirk S, Kerstin W, Jurgen K. Enhanced progression of early carotid atherosclerosis is related to chlamydia pneumoniae seropositivity. Circulation, 2001,103: 1 390-395
  • 9[5]Wald NJ, Law MR, Morris JK, et al. Chlamydia pneumoniae infection and mortality from ischemic heart disease:large prospective study. BMJ, 2000, 321: 204-207
  • 10[6]Paul M. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation, 1999, 99: 1 161-164

共引文献32

同被引文献20

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部